Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CD64 enables TCR-dependent, MHC-independent CTL cytotoxicity of AML cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinations.

Research square·2026

Same author

Deciphering small sequence differences in T cell receptor-antigen pairing.

Nature communications·2026

Same author

First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study.

Journal for immunotherapy of cancer·2026

Same author

FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Cancer immunology research·2026

Same author

B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent manner.

Journal of immunology (Baltimore, Md. : 1950)·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

A multimodal targeting nanoparticle for selectively labeling T cells

Jonathan Gunn¹, Herschel Wallen, Omid Veiseh

¹Department of Materials Science & Engineering University of Washington 302L Roberts Hall Seattle, WA 98195, USA.

Small (Weinheim an Der Bergstrasse, Germany)

|June 6, 2008

Summary

No abstract available in PubMed .

More Related Videos

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Published on: August 22, 2014

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Related Experiment Videos

Last Updated: Jul 4, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Published on: August 22, 2014

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015